Delivery Order SPE2DB22D1200-SPE2DB24FN1DB
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product, MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a potential value of $1,707.42 and a completion date of February 29, 2024. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $1,365.96, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,039.68 and a performance period through March 15, 2024. This delivery order was issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA, which serves as the primary vehicle...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $3,945.00 and a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and is a for-profit organization based in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,269.99 to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The contract has a total potential value of $1,578.00 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order. The contract does not have a set-aside...
- The Defense Logistics Agency (DLA) awarded a $1,578.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $3,449.72 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and operates out of its corporate office in Conshohocken, Pennsylvania. This delivery order is part...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The order has a potential value of $16,788.00 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that regularly provides pharmaceuticals and medical supplies to support U.S. government agencies,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $4,144.74 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, and no set-aside designation was used. Additionally, Amerisourcebergen Drug Corp holds an...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB24FN1DBDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,027.24 to provide MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 3/4/24 |